PAI1 ELISA Kit
Quick Overview for PAI1 ELISA Kit (ABIN411404)
Target
See all PAI1 (SERPINE1) ELISA KitsBinding Specificity
Reactivity
Detection Method
Method Type
Detection Range
Application
Sample Type
-
-
Minimum Detection Limit
- 156 pg/mL
-
Purpose
- Sandwich Human PAI-1 ELISA Kit to quantitate Human SERPINE1 in cell culture supernatants, cell lysates, serum and plasma (heparin, EDTA, citrate ).
-
Analytical Method
- Quantitative
-
Specificity
-
Expression system for standard: NS0
Immunogen sequence: S22-P402Capture antibody and Detection antibody: monoclonal antibody from mouse, polyclonal antibody from goat
-
Cross-Reactivity (Details)
- There is no detectable cross-reactivity with other relevant proteins.
-
Sensitivity
- < 10 pg/mL
-
Components
-
- Pre-coated 96-well strip microplate
- Standard
- Biotinylated antibody (100x)
- Avidin-Biotin-Peroxidase Complex (100x)
- Sample Diluent
- Antibody Diluent
- Avidin-Biotin-Peroxidase Diluent
- Color Developing Reagent (TMB)
- Stop Solution
- Wash Buffer (25x)
- Adhesive plate sealers
-
Material not included
- Microplate Reader capable of reading absorbance at 450nm. Incubator. Automated plate washer (optional). Pipettes and pipette tips capable of precisely dispensing 0.5 μL through 1 mL volumes of aqueous solutions. Multichannel pipettes are recommended for large amount of samples. Deionized or distilled water. 500 mL graduated cylinders. Test tubes for dilution.
-
-
-
-
Application Notes
- Before using Kit, spin tubes and bring down all components to bottom of tube. Duplicate well assay was recommended for both standard and sample testing.
-
Sample Volume
- 100 μL
-
Plate
- Pre-coated
-
Protocol
- ELISA Kit is based on standard sandwich enzyme-linked immune-sorbent assay technology. An antibody has been precoated onto 96-well plates. Standards and test samples are added to the wells, a biotinylated detection antibody specific for target is added subsequently and then followed by washing with PBS or TBS buffer. Avidin-Biotin-Peroxidase Complex was added and unbound conjugates were washed away with PBS or TBS buffer. HRP substrate TMB was used to visualize HRP enzymatic reaction. TMB was catalyzed by HRP to produce a blue color product that changed into yellow after adding acidic stop solution. The density of yellow is proportional to the target amount in sample captured in plate.
-
Assay Precision
-
Intra-Assay Precision (CV%): 6.1%, 7.7%, 7.7%
Inter-Assay Precision (CV%): 7.6%, 7.7%, 8.7% -
Restrictions
- For Research Use only
-
-
-
Handling Advice
- Avoid multiple freeze-thaw cycles.
-
Storage
- -20 °C,4 °C
-
Storage Comment
- Store at 4°C for 6 months, at -20°C for 12 months. Avoid multiple freeze-thaw cycles (Ships with gel ice, can store for up to 3 days in room temperature. Freeze upon receiving.)
-
Expiry Date
- 12 months
-
-
-
: "Cardiometabolic risks vary by weight status in pediatric kidney and liver transplant recipients: A cross-sectional, single-center study in the USA." in: Pediatric transplantation, Vol. 21, Issue 6, (2018) (PubMed).
: "Primed atypical ductal hyperplasia-associated fibroblasts promote cell growth and polarity changes of transformed epithelium-like breast cancer MCF-7 cells via miR-200b/c-IKKβ signaling." in: Cell death & disease, Vol. 9, Issue 2, pp. 122, (2018) (PubMed).
: "Associations between homocysteine metabolism related SNPs and carotid intima-media thickness: a Chinese sib pair study." in: Journal of thrombosis and thrombolysis, Vol. 43, Issue 3, pp. 401-410, (2017) (PubMed).
: "The lost correlation between heat shock protein 70 (HSPA1A) and plasminogen activator inhibitor-1 in patients with type 2 diabetes and albuminuria." in: Cell stress & chaperones, Vol. 21, Issue 2, pp. 361-5, (2016) (PubMed).
: "Disequilibrium of Blood Coagulation and Fibrinolytic System in Patients With Coronary Artery Ectasia." in: Medicine, Vol. 95, Issue 8, pp. e2779, (2016) (PubMed).
: "Suppression of plasminogen activator inhibitor-1 by inhaled nitric oxide attenuates the adverse effects of hyperoxia in a rat model of acute lung injury." in: Thrombosis research, Vol. 136, Issue 1, pp. 131-8, (2015) (PubMed).
-
-
- PAI1 (SERPINE1) (Plasminogen Activator Inhibitor 1 (SERPINE1))
-
Alternative Name
- Plasminogen activator inhibitor-1 (PAI-1)
-
Background
-
Background: Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator (tPA) and urokinase (uPA), the activators of plasminogen and hence fibrinolysis (the physiological breakdown of blood clots). It is a serine protease inhibitor (serpin) protein (SERPINE1). PAI-1 is mainly produced by the endothelium (cells lining blood vessels), but is also secreted by other tissue types, such as adipose tissue. The PAI-1 gene is located on the seventh chromosome (7q21.3-q22).1 Congenital deficiency of PAI-1 leads to a hemorrhagic diathesis (a tendency to hemorrhage). PAI-1 is present in increased levels in various disease states (such as a number of forms of cancer), as well as in obesity and the metabolic syndrome. It has been linked to the increased occurrence of thrombosis in patients with these conditions. Additionally, it has been shown to interact with ORM1.2 The standard product used in this kit is recombinant human PAI-1 with the molecular mass of 43KDa.
Gene Full Name: serpin family E member 1
-
Gene ID
- 5054
-
UniProt
- P05121
-
Pathways
- p53 Signaling, Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Autophagy, Smooth Muscle Cell Migration
Target See all PAI1 (SERPINE1) ELISA Kits
-